Bryan Lubel - 22 May 2024 Form 4 Insider Report for KORE Group Holdings, Inc. (KORE)

Reporting relationship
Exec. VP., Connected Health
Issuer ticker
KORE
Reported as of
22 May 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 May 2024, 16:12:57 UTC
Prior SEC filing
08 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Jack W. Kennedy Jr., Attorney-in-Fact for Bryan Lubel

Key filing fact

Bryan Lubel filed Form 4 for KORE Group Holdings, Inc. (KORE) on 24 May 2024.

Key facts

  • This page summarizes Bryan Lubel's Form 4 filing for KORE Group Holdings, Inc. (KORE).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 24 May 2024, 16:12.

Change

  • Previous filing in this sequence was filed on 08 Apr 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KORE transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+140,000
Change %
Price
$0.000000
Shares after
140,000
Date
22 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
140,000
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.

Footnote F2

The reported RSUs will vest in three equal installments on each of the first three anniversaries of May 22, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .